HTTP/1.0 200 OK Cache-Control: private, must-revalidate Content-Type: text/html; charset=UTF-8 Date: Thu, 26 Nov 2020 13:01:47 GMT Expires: -1 Pragma: no-cache 飞禽走兽提现app
中国钢厂4月日产量创新高 G7或联手施压中国钢铁

COVID-19 is an emerging, rapdily evolving situation


Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: 超四成建材公司净利润同比下滑 疲软态势延续亟需转型升级

Get the latest COVID-19 GWAS Results from GRASP: 韩2015年家具销售额创9年新高 或为宜家效应

 

COVID-19 GWAS Results -- for public download/use

This site compiles COVID-19 genetic scan results for immediate public download and use from any source permitting such use. Right click links provided here and select “open link in a new tab” to stay on this webpage.

Prior to 07/14/2020: The use of the term “positive” below denotes a positive or assumed positive COVID-19 case based on study definitions. “Negative” indicates someone who has tested negative or presumed negative based on study definitions for COVID-19. “Unknown” indicates population control samples who may not have been tested or may not yet have results.

Between 07/14/2020 and 09/08/2020: COVID-19 deaths (CD 10 U071) or inpatient diagnosis of COVID-19 (ICD 10 U071) were also added to “positive”. When new death data are released by UK BioBank, six COVID-19 death GWAS will be conducted in addition to COVID-19 GWAS.

From 10/16/2020 and on: COVID-19 deaths (ICD 10 U071), inpatient diagnosis of COVID-19 (ICD 10 U071), primary care clinical data (both TPP/CTV3 and EMIS/SNOMED CT coding systems – see below) were also added to “positive”.

COVID-19 in TPP/CTV3 coding system (01/31/2020 or later)
Y228d: Coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 confirmed by laboratory test (situation)
Y20d1: Severe acute respiratory syndrome coronavirus 2 detected (finding)
Y20fa: Coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 (disorder)
Y210a: Pneumonia caused by severe acute respiratory syndrome coronavirus 2 (disorder)
Y210b: Infection of upper respiratory tract caused by severe acute respiratory syndrome coronavirus 2 (disorder)
Y210e: Detection of severe acute respiratory syndrome coronavirus 2 using polymerase chain reaction technique (procedure)
Y23f7: SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) detection result positive

COVID-19 in EMIS/SNOMED CT coding system (01/31/2020 or later)
EMISNQCO303: 2019-nCoV (Wuhan) infection
186747009: Coronavirus infection (disorder)
12802201000006101: Confirmed 2019-nCoV (novel coronavirus) infection
1240581000000104: 2019-nCoV (novel coronavirus) detected
1300721000000109: Coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 confirmed by laboratory test (situation)
1240751000000100: Disease caused by 2019-nCoV (novel coronavirus)
1240561000000108: Encephalopathy caused by 2019-nCoV (novel coronavirus)
1240571000000101: Gastroenteritis caused by 2019-nCoV (novel coronavirus)
1240531000000103: Myocarditis caused by 2019-nCoV (novel coronavirus)
1240521000000100: Otitis media caused by 2019-nCoV (novel coronavirus)
1240551000000105: Pneumonia caused by 2019-nCoV (novel coronavirus)
1240541000000107: Upper respiratory tract infection caused by 2019-nCoV (novel coronavirus)
1240511000000106: Detection of 2019-nCoV (novel coronavirus) using polymerase chain reaction technique
1240381000000105: Severe acute respiratory syndrome coronavirus 2 (organism)

From 11/03/2020 and on: We added hospitalized COVID-19 GWAS and severe COVID-19 GWAS with primary care data (both TPP and EMIS) being released by UKBB. A hospitalized COVID-19 case is defined by a sample with inpatient diagnosis of COVID-19 (ICD 10 U071). A severe COVID-19 case is defined by a sample with COVID-19 death (ICD 10 U071) or with inpatient diagnosis of both COVID-19 and dependence on respirator (ICD 10 Z991 and Z9911) in the same instance index, or a COVID-10 case with advanced respiratory support (from inpatient critical care data). Due to limited case samples, currently we only conducted both hospitalized and sever COVID-19 GWAS for European and overall samples in UKBB – with 3 additional non-European GWAS for hospitalized COVID-19.

After each COVID-19 release of UK Biobank data (门禁市场现状:安防网络化下需开放融合) we are calculating GWAS summary statistics and releasing them to this site.

  • GWAS were conducted with SAIGE (LED照明行业剧烈洗牌 4000家企业将退出) adjusted for baseline age, sex and 10 principal components
  • 7. 《教师》(The Kindergarten Teacher)。在这部严酷、怪异的轰动之作中,以色列导演那达夫·拉皮德(Nadav Lapid)讲述一个教师对一个儿童诗人的迷恋,为狂热及其代价绘制了一幅残忍的肖像。
    2. Audiologist
  • Two analyses (06/05/2020 or earlier):
    • 其中,上海交易所IPO共计26宗,而深圳中小企业板IPO共计15宗,创业板IPO共计20宗。
    • 伦敦——自2002年开设以来,“周六人物”(Saturday Profile)便旨在向《纽约时报》的读者介绍世界各地的人。读者可能从来没有听说过这些人,但他们过着有趣的生活,做过不同寻常的事情,或者刚刚有了一段非凡的经历。
  • Eighteen analyses (06/18/2020):
    • COVID-19 positive vs. COVID-19 negative in ALL UKBB tested samples (files with name UKBB_covid19_ALLtested)
    • COVID-19 positive vs. COVID-19 negative or untested in ALL UKBB samples (files with name UKBB_covid19_ALL)
    • COVID-19 positive vs. COVID-19 negative in European (EUR) UKBB tested samples (files with name UKBB_covid19_EURtested)
    • COVID-19 positive vs. COVID-19 negative or untested in European (EUR) UKBB samples (files with name UKBB_covid19_EUR)
    • COVID-19 positive vs. COVID-19 negative in ALL Female UKBB tested samples (files with name UKBB_covid19_ALLtested_F)
    • COVID-19 positive vs. COVID-19 negative or untested in ALL Female UKBB samples (files with name UKBB_covid19_ALL_F)
    • COVID-19 positive vs. COVID-19 negative in European (EUR) Female UKBB tested samples (files with name UKBB_covid19_EURtested_F)
    • COVID-19 positive vs. COVID-19 negative or untested in European (EUR) Female UKBB samples (files with name UKBB_covid19_EUR_F)
    • COVID-19 positive vs. COVID-19 negative in ALL Male UKBB tested samples (files with name UKBB_covid19_ALLtested_M)
    • COVID-19 positive vs. COVID-19 negative or untested in ALL Male UKBB samples (files with name UKBB_covid19_ALL_M)
    • COVID-19 positive vs. COVID-19 negative in European (EUR) Male UKBB tested samples (files with name UKBB_covid19_EURtested_M)
    • COVID-19 positive vs. COVID-19 negative or untested in European (EUR) Male UKBB samples (files with name UKBB_covid19_EUR_M)
    • COVID-19 positive vs. COVID-19 negative in African (AFR) UKBB tested samples (files with name UKBB_covid19_AFRtested)
    • COVID-19 positive vs. COVID-19 negative or untested in African (AFR) UKBB samples (files with name UKBB_covid19_AFR)
    • COVID-19 positive vs. COVID-19 negative in South Asian (SAS) UKBB tested samples (files with name UKBB_covid19_SAStested)
    • COVID-19 positive vs. COVID-19 negative or untested in South Asian (SAS) UKBB samples (files with name UKBB_covid19_SAS)
    • COVID-19 positive vs. COVID-19 negative in OTHER ancestry UKBB tested samples (files with name UKBB_covid19_OTHERtested)
    • COVID-19 positive vs. COVID-19 negative or untested in OTHER ancestry UKBB samples (files with name UKBB_covid19_OTHER)
  • Six COVID-19 death analyses in addition to above 18 analyses (07/14/2020):
    • COVID-19 death vs. COVID-19 negative or untested in ALL UKBB samples (files with name UKBB_death_ALL)
    • COVID-19 death vs. COVID-19 negative or untested in European (EUR) UKBB samples (files with name UKBB_death_EUR)
    • COVID-19 death vs. COVID-19 positive survivors in ALL UKBB tested positive samples (files with name UKBB_death_ALLpstv)
    • COVID-19 death vs. COVID-19 positive survivors in European (EUR) UKBB tested positive samples (files with name UKBB_death_EURpstv)
    • COVID-19 death vs. COVID-19 positive survivors and negative in ALL UKBB tested samples (files with name UKBB_death_ALLtested)
    • COVID-19 death vs. COVID-19 positive survivors and negative in European (EUR) UKBB tested samples (files with name UKBB_death_EURtested)
  • Two analyses in addition to the above 24 analyses (08/04/2020):
    • COVID-19 positive vs. COVID-19 negative in non-European (nEUR) UKBB tested samples (files with name UKBB_covid19_nEURtested)
    • COVID-19 positive vs. COVID-19 negative or untested in non-European (nEUR) UKBB samples (files with name UKBB_covid19_nEUR)
  • Twenty-one hospitalized COVID-19 analyses (11/03/2020):
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive in ALL UKBB tested positive samples (files with name UKBB_hsptl_ALLpstv)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive and COVID-19 negative in ALL UKBB tested samples (files with name UKBB_hsptl_ALLtested)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive, COVID-19 negative or untested in ALL UKBB samples (files with name UKBB_hsptl_ALL)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive in European (EUR) UKBB tested positive samples (files with name UKBB_hsptl_EURpstv)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive and COVID-19 negative in EUR UKBB tested samples (files with name UKBB_hsptl_EURtested)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive, COVID-19 negative or untested in EUR UKBB samples (files with name UKBB_hsptl_EUR)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive in non-European (nEUR) UKBB tested positive samples (files with name UKBB_hsptl_nEURpstv)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive and COVID-19 negative in nEUR UKBB tested samples (files with name UKBB_hsptl_nEURtested)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive, COVID-19 negative or untested in nEUR UKBB samples (files with name UKBB_hsptl_nEUR)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive in ALL Female UKBB tested positive samples (files with name UKBB_hsptl_ALLpstv_F)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive and COVID-19 negative in ALL Female UKBB tested samples (files with name UKBB_hsptl_ALLtested_F)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive, COVID-19 negative or untested in ALL Female UKBB samples (files with name UKBB_hsptl_ALL_F)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive in EUR Female UKBB tested positive samples (files with name UKBB_hsptl_EURpstv_F)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive and COVID-19 negative in EUR Female UKBB tested samples (files with name UKBB_hsptl_EURtested_F)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive, COVID-19 negative or untested in EUR Female UKBB samples (files with name UKBB_hsptl_EUR_F)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive in ALL Male UKBB tested positive samples (files with name UKBB_hsptl_ALLpstv_M)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive and COVID-19 negative in ALL Male UKBB tested samples (files with name UKBB_hsptl_ALLtested_M)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive, COVID-19 negative or untested in ALL Male UKBB samples (files with name UKBB_hsptl_ALL_M)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive in EUR Male UKBB tested positive samples (files with name UKBB_hsptl_EURpstv_M)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive and COVID-19 negative in EUR Male UKBB tested samples (files with name UKBB_hsptl_EURtested_M)
    • Hospitalized COVID-19 positive vs. non-hospitalized COVID-19 positive, COVID-19 negative or untested in EUR Male UKBB samples (files with name UKBB_hsptl_EUR_M)
  • Eighteen severe COVID-19 analyses (11/03/2020):
    • Severe COVID-19 positive vs. non-severe COVID-19 positive in ALL UKBB tested positive samples (files with name UKBB_severe_ALLpstv)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive and COVID-19 negative in ALL UKBB tested samples (files with name UKBB_severe_ALLtested)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive, COVID-19 negative or untested in ALL UKBB samples (files with name UKBB_severe_ALL)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive in European (EUR) UKBB tested positive samples (files with name UKBB_severe_EURpstv)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive and COVID-19 negative in EUR UKBB tested samples (files with name UKBB_severe_EURtested)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive, COVID-19 negative or untested in EUR UKBB samples (files with name UKBB_severe_EUR)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive in ALL Female UKBB tested positive samples (files with name UKBB_severe_ALLpstv_F)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive and COVID-19 negative in ALL Female UKBB tested samples (files with name UKBB_severe_ALLtested_F)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive, COVID-19 negative or untested in ALL Female UKBB samples (files with name UKBB_severe_ALL_F)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive in EUR Female UKBB tested positive samples (files with name UKBB_severe_EURpstv_F)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive and COVID-19 negative in EUR Female UKBB tested samples (files with name UKBB_severe_EURtested_F)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive, COVID-19 negative or untested in EUR Female UKBB samples (files with name UKBB_severe_EUR_F)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive in ALL Male UKBB tested positive samples (files with name UKBB_severe_ALLpstv_M)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive and COVID-19 negative in ALL Male UKBB tested samples (files with name UKBB_severe_ALLtested_M)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive, COVID-19 negative or untested in ALL Male UKBB samples (files with name UKBB_severe_ALL_M)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive in EUR Male UKBB tested positive samples (files with name UKBB_severe_EURpstv_M)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive and COVID-19 negative in EUR Male UKBB tested samples (files with name UKBB_severe_EURtested_M)
    • Severe COVID-19 positive vs. non-severe COVID-19 positive, COVID-19 negative or untested in EUR Male UKBB samples (files with name UKBB_severe_EUR_M)

Summary statistics are for UK Biobank (v.3) imputed genome-wide association (GWAS) studies of COVID-19 test positives with variant filters of imputation quality INFO score >0.3, minor allele count (MAC) > 2, minor allele frequency > 0.0001. Note allele2 is coded allele. See SAIGE output description here: For now, most of the activity around bitcoin is monetary in nature, so it makes sense that its critics point to volatility. Though the value of one bitcoin in U.S. dollars has fallen 67% in the past year, its value over the past two years is up 1,879%, according to the market price chart at blockchain.info. So whether it’s a good investment or a bad one is a matter of perspective..

Ellinghaus, Degenhardt et al.
Meta-analysis of Spanish and Italian COVID19 cases with respiratory failure
NOTE: full GWAS files are GRCh38 build position whereas top results and annotated files have been Lifted Over to GRCh37.

COVID-19 Host Genetics initiative results provided under Creative Commons License. This includes meta-analyses of international case/control samples with a larger sample size than UKBB alone. These analyses may also have greater test/population ascertainment and genetic heterogeneity effects. If you have samples to contribute we urge you to consider joining. See also 房企新“王”加冕 保位谋多元化转型? and 全国住建工作会议为2018年房地产发展指明方向

《大唐荣耀》

  • Variant chromosomes, positions and alleles were mapped to SNP rsIDs with CellBase REST API (梅州市将建设一站式油漆涂料市场 described in 微电影营销 品牌你投对了吗?
  • 马拉比这部长达800页的作品今年10月由布鲁姆斯伯里出版社(Bloomsbury)和企鹅出版社(Penguin Press)出版。英国《金融时报》的一篇书评称赞该书“非比寻常”。该书是在同终选名单中的另外五部作品展开激烈竞争后脱颖而出的。另五部作品尝试解决的是世界上一些重要的经济与管理难题——从美国的生产率缺口,到持续存在的性别失衡。
    China will continue to improve market environment and tap consumption potential while developing complementary cross-border industrial and value chain with countries along the Belt and Road Initiative in the next five years, according to Gao.
  • Variant annotations were queried against ANNOVAR and CADD (v.1.6).
    Descriptions of annotation columns are found here
  • Expression QTLs were annotated with GTeX v.8 (瞭望|雄安新区“新”在何处) and with a literature based database of cis/trans eQTLs (many described in 石家庄今年首批公共保障房公示期满 部分小区开始办理入住)

All files are in compressed Gzip format.
Send questions, comments or requests to add data or analysis to: ming-huei.chen@nih.gov, florian.thibord@nih.gov, and johnsonad2@nih.gov


Data Source Release Date Description # Cases / Controls Ancestry    Sex    # variants (Million) # Top (P<1E-5) Summary Stats(full) Top Annotated Top in Grasp Top in EBI Top in GTeX Top in eQTLdb     Comments    
UKBB 11.03.20 Positive vs. Negative (tested) 3,962 / 25,845 European M and F 38.06M 427 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Population 3,962 / 455,288 European M and F 38.06M 500 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Negative (tested) 4,372 / 27,629 Mixed M and F 48.73M 511 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Population 4,372 / 482,948 Mixed M and F 47.70M 648 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Negative (tested) 130 / 508 African M and F 24.76M 154 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Population 130 / 7,514 African M and F 43.68M 352 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Negative (tested) 180 / 645 South Asian M and F 16.96M 181 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Population 180 / 9,237 South Asian M and F 41.98M 290 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Negative (tested) 100 / 631 Other M and F 23.15M 276 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Population 100 / 10,909 Other M and F 61.41M 420 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Negative (tested) 410 / 1,784 Non European M and F 35.82M 374 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Population 410 / 27,660 Non European M and F 66.62M 477 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Negative (tested) 1,953 / 13,591 European F 37.95M 348 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Population 1,953 / 247,346 European F 38.11M 363 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Negative (tested) 2,159 / 14,564 Mixed F 42.21M 504 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Population 2,159 / 262,070 Mixed F 47.88M 395 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Negative (tested) 2,009 / 12,254 European M 37.43M 397 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Population 2,009 / 207,942 European M 37.98M 491 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Negative (tested) 2,213 / 13,065 Mixed M 47.81M 442 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive vs. Population 2,213 / 220,878 Mixed M 47.45M 521 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive and Death vs. Population 418 / 486,902 Mixed M and F 47.70M 450 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive and Death vs. Population 377 / 458,873 European M and F 38.06M 348 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive and Death vs. Positive Survivor 418 / 3,954 Mixed M and F 33.64M 298 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive and Death vs. Positive Survivor 377 / 3,585 European M and F 24.36M 202 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive and Death vs. Tested Survivor 418 / 31,583 Mixed M and F 48.73M 573 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Positive and Death vs. Tested Survivor 377 / 29,430 European M and F 38.07M 363 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 678 / 458,572 European M and F 38.06M 575 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive 678 / 3,284 European M and F 24.36M 271 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 678 / 29,129 European M and F 38.07M 524 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 794 / 486,526 Mixed M and F 47.70M 522 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive 794 / 3,578 Mixed M and F 33.64M 376 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 794 / 31,207 Mixed M and F 48.73MM 573 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 116 / 27,954 Non European M and F 66.62M 434 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive 116 / 294 Non European M and F 20.80M 140 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 116 / 2,078 Non European M and F 35.82M 227 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 246 / 249,053 European F 38.11M 311 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive 246 / 1,707 European F 19.11M 145 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 246 / 15,298 European F 37.95M 281 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 297 / 263,932 Mixed F 47.88M 378 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive 297 / 1,862 Mixed F 26.19M 151 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 297 / 16,426 Mixed F 49.21M 454 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 432 / 209,519 European M 37.98M 372 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive 432 / 1,577 European M 19.24M 187 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 432 / 13,831 European M 37.43M 424 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive or Negative or Untested 497 / 222,594 Mixed M 47.45M 484 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive 497 / 1,716 Mixed M 25.51M 215 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Hospitalized Positive vs. Non-Hospitalized Positive or Negative 497 / 14,781 Mixed M 47.81M 532 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive or Negative or Untested 421 / 458,829 European M and F 38.06M 384 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive 421 / 3,541 European M and F 24.36M 200 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive or Negative 421 / 29,386 European M and F 38.07M 273 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive or Negative or Untested 474 / 486,846 Mixed M and F 47.70M 378 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive 474 / 3,898 Mixed M and F 33.64M 348 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive or Negative 474 / 31,527 Mixed M and F 48.73M 436 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive or Negative or Untested 146 / 249,153 European F 38.11M 276 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive 146 / 1,807 European F 19.11M 233 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive or Negative 146 / 15,398 European F 37.95M 269 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive or Negative or Untested 171 / 264,058 Mixed F 47.88M 441 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive 171 / 1,988 Mixed F 26.19M 235 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive or Negative 171 / 16,552 Mixed F 49.21M 488 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive or Negative or Untested 275 / 209,676 European M 37.98M 329 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive 275 / 1,734 European M 19.24M 168 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive or Negative 275 / 13,988 European M 37.43M 284 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive or Negative or Untested 303 / 222,788 Mixed M 47.45M 296 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive 303 / 1,910 Mixed M 25.51M 177 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 11.03.20 Severe Positive vs. Non-Severe Positive or Negative 303 / 14,975 Mixed M 47.81M 325 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Negative (tested) 2,727 / 23,249 European M and F 38.03M 323 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Population 2,727 / 456,523 European M and F 38.06M 389 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Negative (tested) 3,050 / 24,853 Mixed M and F 48.79M 426 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Population 3,050 / 484,270 Mixed M and F 47.70M 451 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Negative (tested) 114 / 452 African M and F 24.05M 171 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Population 114 / 7,530 African M and F 43.68M 272 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Negative (tested) 133 / 587 South Asian M and F 16.21M 173 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Population 133 / 9,284 South Asian M and F 41.98M 485 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Negative (tested) 76 / 565 Other M and F 22.15M 179 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Population 76 / 10,933 Other M and F 61.41M 260 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Negative (tested) 323 / 1,604 Non European M and F 34.25M 278 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Population 323 / 27,747 Non European M and F 66.62M 223 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Negative (tested) 1,325 / 12,172 European F 36.92M 354 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Population 1,325 / 247,974 European F 38.11M 523 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Negative (tested) 1,485 / 13,040 Mixed F 48.88M 422 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Population 1,485 / 262,744 Mixed F 47.88M 484 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Negative (tested) 1,402 / 11,077 European M 36.05M 349 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Population 1,402 / 208,549 European M 37.98M 332 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Negative (tested) 1,565 / 11,813 Mixed M 46.48M 406 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 10.16.20 Positive vs. Population 1,565 / 221,526 Mixed M 47.45M 432 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive and Death vs. Population 416 / 486,904 Mixed M and F 47.70M 450 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive and Death vs. Population 375 / 458,875 European M and F 38.06M 365 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive and Death vs. Positive Survivor 416 / 1,405 Mixed M and F 25.98M 159 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive and Death vs. Positive Survivor 375 / 1,207 European M and F 17.85M 117 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive and Death vs. Tested Survivor 416 / 17,302 Mixed M and F 49.04M 722 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive and Death vs. Tested Survivor 375 / 16,068 European M and F 37.96M 442 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Negative (tested) 1,582 / 14,861 European M and F 37.96M 333 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Population 1,582 / 457,668 European M and F 38.06M 419 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Negative (tested) 1,821 / 15,897 Mixed M and F 49.04M 374 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Population 1,821 / 485,499 Mixed M and F 47.70M 437 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Negative (tested) 96 / 288 African M and F 21.83M 102 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Population 96 / 7,548 African M and F 43.68M 311 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Negative (tested) 80 / 362 South Asian M and F 13.89M 135 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Population 80 / 9,337 South Asian M and F 41.98M 548 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Negative (tested) 63 / 386 Other M and F 19.92M 70 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Population 63 / 10,946 Other M and F 61.41M 189 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Negative (tested) 239 / 1,036 Non European M and F 29.78M 250 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Population 239 / 27,831 Non European M and F 66.62M 238 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Negative (tested) 736 / 7,709 European F 32.00M 311 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Population 736 / 248,563 European F 38.11M 482 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Negative (tested) 851 / 8,271 Mixed F 42.92M 420 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Population 851 / 263,378 Mixed F 47.88M 300 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Negative (tested) 846 / 7,152 European M 31.40M 311 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Population 846 / 209,105 European M 37.98M 459 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Negative (tested) 970 / 7,626 Mixed M 40.61M 339 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 09.08.20 Positive vs. Population 970 / 222,121 Mixed M 47.45M 708 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Negative (tested) 1,503 / 10,632 European M and F 35.77M 344 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Population 1,503 / 457,747 European M and F 38.06M 408 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Negative (tested) 1,723 / 11,409 Mixed M and F 47.68M 340 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Population 1723 / 485,597 Mixed M and F 47.70M 411 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Negative (tested) 88 / 229 African M and F 20.84M 98 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Population 88 / 7,556 African M and F No change since 07.14.20 analysis
UKBB 08.04.20 Positive vs. Negative (tested) 73 / 254 South Asian M and F 12.77M 137 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Population 73 / 9,344 South Asian M and F 41.98M 636 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Negative (tested) 59 / 294 Other M and F 18.49M 71 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Population 59 / 10,950 Other M and F 61.41M 121 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Negative (tested) 220 / 777 Non European M and F 27.56M 209 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Population 220 / 27,850 Non European M and F 66.62M 315 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Negative (tested) 699 / 5,452 European F 28.66M 205 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Population 699 / 248,600 European F 38.11M 352 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Negative (tested) 804 / 5,887 Mixed F 39.16M 285 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Population 804 / 263,425 Mixed F 47.88M 315 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Negative (tested) 804 / 5,180 European M 28.35M 300 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Population 804 / 209,147 European M 37.98M 450 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Negative (tested) 919 / 5,522 Mixed M 37.00M 519 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 08.04.20 Positive vs. Population 919 / 222,172 Mixed M 47.45M 590 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive and Death vs. Population 364 / 486,956 Mixed M and F 47.70M 437 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive and Death vs. Population 325 / 458,925 European M and F 38.06M 365 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive and Death vs. Positive Survivor 364 / 1,306 Mixed M and F 25.16M 127 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive and Death vs. Positive Survivor 325 / 1,129 European M and F 17.38M 130 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive and Death vs. Tested Survivor 364 / 8,874 Mixed M and F 47.70M 403 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive and Death vs. Tested Survivor 325 / 8,161 European M and F 31.99M 288 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Negative (tested) 1,454 / 7,032 European M and F 31.99M 293 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Population 1,454 / 457,796 European M and F 38.06M 385 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Negative (tested) 1,670 / 7,568 Mixed M and F 43.28M 304 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Population 1,670 / 485,650 Mixed M and F 47.70M 426 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Negative (tested) 88 / 167 African M and F 19.75M 70 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Population 88 / 7,556 African M and F 43.68M 334 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Negative (tested) 70 / 167 South Asian M and F 11.77M 69 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Population 70 / 9,347 South Asian M and F 41.98M 761 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Negative (tested) 58 / 202 Other M and F 16.94M 46 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Population 58 / 10,951 Other M and F 61.41M 228 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Negative (tested) 674 / 3,611 European F 25.20M 260 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Population 674 / 248,625 European F 38.11M 345 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Negative (tested) 778 / 3,917 Mixed F 35.00M 371 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Population 778 / 263,451 Mixed F 47.88M 404 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Negative (tested) 780 / 3,421 European M 25.03 244 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Population 780 / 209,171 European M 37.98M 393 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Negative (tested) 892 / 3,651 Mixed M 32.98M 418 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 07.14.20 Positive vs. Population 892 / 222,199 Mixed M 47.45M 597 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Negative (tested) 1,291 / 5,455 European M and F 29.61M 304 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Population 1,291 / 457,959 European M and F 38.06M 379 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Negative (tested) 1,485 / 5,877 Mixed M and F 40.32M 269 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Population 1,485 / 485,835 Mixed M and F 47.70M 395 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Negative (tested) 77 / 135 African M and F 18.87M 93 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Population 77 / 7,567 African M and F 43.68M 293 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Negative (tested) 64 / 135 South Asian M and F 11.29M 47 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Population 64 / 9,353 South Asian M and F 41.98M 722 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Negative (tested) 53 / 152 Other M and F 15.58M 89 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Population 53 / 10,956 Other M and F 61.41M 200 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Negative (tested) 610 / 2,779 European F 22.13M 228 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Population 610 / 248,689 European F 38.11M 447 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Negative (tested) 701 / 3,014 Mixed F 32.30M 308 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Population 701 / 263,528 Mixed F 47.88M 265 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Negative (tested) 681 / 2,676 European M 23.09M 338 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Population 681 / 209,270 European M 37.98M 337 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Negative (tested) 784 / 2,863 Mixed M 30.60M 313 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.18.20 Positive vs. Population 784 / 222,307 Mixed M 47.45M 419 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 06.05.20 Positive vs. Negative (tested) 1,221 / 4,117 European M and F 27.26 M 244 Summary Stats Annotated Grasp EBI GTeX eQTLdb
UKBB 06.05.20 Positive vs. Population 1,221 / 458,029 European M and F 38.06 M 406 Summary Stats Annotated Grasp EBI GTeX eQTLdb
UKBB 05.25.20 Positive vs. Negative (tested) 1,095/ 2,797 European M and F 24.33 M 172 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.25.20 Positive vs. Population 1,095 / 458,155 European M and F 38.06 M 448 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.07.20 Positive vs. Negative (tested) 880 / 1,686 European M and F 21.03 M 205 Summary Stats Annotated Grasp EBI GTeX eQLdb
UKBB 05.07.20 Positive vs. Population 880 / 458,370 European M and F 38.06 M 374 Summary Stats Annotated Grasp EBI GTeX eQLdb
Ellinghaus et al (link) 06.17.20 Covid-19 cases with respiratory failure vs Healthy controls 1,610 / 2,205 European M and F 8.58 M 391 Summary Stats Annotated Grasp EBI GTeX eQLdb GWAS adjusted for 10 PCs; Tops were lifted to hg19
Ellinghaus et al (link) 06.17.20 Covid-19 cases with respiratory failure vs Healthy controls 1,610 / 2,205 European M and F 8.58 M 317 Summary Stats Annotated Grasp EBI GTeX eQLdb GWAS adjusted for 10 PCs + age + sex; Tops were lifted to hg19
COVID19hg (link) 10.20.20 Very severe respiratory confirmed covid vs. not hospitalized covid (A1) 269 / 688 Mixed M and F 9.30M 81 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hg (link) 10.20.20 Very severe respiratory confirmed covid vs. population (A2) 4,336 / 623,902 Mixed M and F 11.83M 949 Summary Stats Annotated Grasp EBI GTeX eQLdb These results do not include the 23andMe study. A limited version including 23andMe is available on the Covid19-hg website
COVID19hg (link) 10.20.20 Hospitalized covid vs. not hospitalized covid (B1) 2,430 / 8,478 Mixed M and F 14.90M 368 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hg (link) 10.20.20 Hospitalized covid vs. population (B2) 6,406 / 902,088 European M and F 9.87M 2394 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hg (link) 10.20.20 Hospitalized covid vs. population (B2) 7,885 / 961,804 Mixed M and F 11.43M 2748 Summary Stats Annotated Grasp EBI GTeX eQLdb These results do not include the 23andMe study. A limited version including 23andMe is available on the Covid19-hg website
COVID19hg (link) 10.20.20 Covid vs. lab/self-reported negative (C1) 11,085 / 116,794 Mixed M and F 13.06M 224 Summary Stats Annotated Grasp EBI GTeX eQLdb These results do not include the 23andMe study. A limited version including 23andMe is available on the Covid19-hg website
COVID19hg (link) 10.20.20 Covid vs. population (C2) 17,965 / 1,370,547 Mixed M and F 11.58M 541 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hg (link) 10.20.20 Covid vs. population (C2) 14,134 / 1,284,876 European M and F 12.71M 396 Summary Stats Annotated Grasp EBI GTeX eQLdb These results do not include the 23andMe study. A limited version including 23andMe is available on the Covid19-hg website
COVID19hg (link) 10.20.20 Predicted covid from self-reported symptoms vs. predicted or self-reported non-covid (D1) 3,204 / 35,728 Mixed M and F 11.48M 88 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hg (link) 09.30.20 Very severe respiratory confirmed vs. population (A2 alpha) 2,972 / 284,472 Mixed M and F 12.82M 886 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hg (link) 09.30.20 Hospitalized covid vs. Not hospitalized covid (B1 alpha) 1,389 / 5,879 Mixed M and F 9.47M 66 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hg (link) 09.30.20 Hospitalized covid vs. Population (B2 alpha) 6,492 / 1,012,809 Mixed M and F 10.53M 978 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hg (link) 09.30.20 Covid vs. Lab/self-reported negative (C1 alpha) 11,181 / 116,456 Mixed M and F 13.91M 247 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hg (link) 09.30.20 Covid vs. Population (C2 alpha) 17,607 / 1,345,334 Mixed M and F 13.06M 476 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hg (link) 09.30.20 Predicted covid from self-reported symptoms vs. Predicted or self-reported non-covid (D1 alpha) 1,777 / 18,895 Mixed M and F 13.82M 106 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hgi (link) 06.26.20 Positive with severe respiratory vs. Population 536 / 329,391 Mixed M and F 9.31 M 60 Summary Stats Annotated Grasp EBI GTeX eQLdb Tops were lifted to hg19
COVID19hgi (link) 06.26.20 Positive Hospitalized vs. Positive Non Hospitalized 928 / 2,028 European M and F 12.03 M 130 Summary Stats Annotated Grasp EBI GTeX eQLdb Tops were lifted to hg19
COVID19hgi (link) 06.26.20 Positive Hospitalized vs. Population 3,199 / 897,488 Mixed M and F 15.39 M 453 Summary Stats Annotated Grasp EBI GTeX eQLdb Tops were lifted to hg19
COVID19hgi (link) 06.26.20 Positive vs. Lab/self reported Negative 3,523 / 36,634 Mixed M and F 22.04 M 153 Summary Stats Annotated Grasp EBI GTeX eQLdb Tops were lifted to hg19
COVID19hgi (link) 06.26.20 Positive vs. Population 6,696 / 1,073,072 Mixed M and F 20.59 M 377 Summary Stats Annotated Grasp EBI GTeX eQLdb Tops were lifted to hg19
COVID19hgi (link) 06.26.20 Positive (predict/self report) vs. Negative (predict/self report) 1,865 / 29,174 European M and F 12.27 M 169 Summary Stats Annotated Grasp EBI GTeX eQLdb Tops were lifted to hg19
COVID19hgi (link) 05.13.20 Positive Hospitalized vs. Positive Non Hospitalized 716 / 616 Mixed M and F 10.98 M 958 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hgi (link) 05.13.20 Positive vs. Population 1,678 / 674,635 Mixed M and F 34.01 M 3,262 Summary Stats Annotated Grasp EBI GTeX eQLdb
COVID19hgi (link) 05.13.20 Positive (predict/self report) vs. Negative (predict/self report) 1,294 / 26,969 European M and F 7.52 M 544 Summary Stats Annotated Grasp EBI GTeX eQLdb



This work was supported by the NHLBI Intramural Research program and the NIH Biowulf high performance computing cluster (https://hpc.nih.gov/).